Department of Otorhinolaryngology-Head and Neck Surgery, Hallym University School of Medicine, Seoul, Korea.
Cancer Biomark. 2012;12(3):115-24. doi: 10.3233/CBM-130299.
The aim of this study was to examine the pattern of SNPs in ECRG1 and FGFR4 gene of oral squamous cell carcinoma, and to evaluate the association between SNPs and prognostic parameters.
Total 24 cases of oral squamous cell carcinoma patients were enrolled in this study. We analyzed the pattern of SNPs in ECRG1 and FGFR4 gene using PCR and direct sequence. Also we evaluated the association between SNPs pattern and clinicopathologic parameters of oral squamous cell carcinoma.
The allele type Arg/Arg in ECRG1 gene was found in 13 (54.2%) patients, Arg/Gln in 11 (45.8%) patients and Gln/Gln in no patient. No clinical or pathological factor was associated with the SNP pattern in ECRG1. The allele types of FGFR4 amino acid 388 in 24 OSCC patients were Arg/Arg (8.3%), Arg/Gly (54.2%) and Gly/Gly (37.5%). No clinical or pathological factor was significantly associated with the SNP pattern except the nodal stage. The patients carrying FGFR4 allele Arg/Arg or Arg/Gly at amino acid 388 were associated with advanced N stage (pathologic N2+N3), compared to Gly/Gly allele carrying group (p=0.009).
This study is the first to describe a SNP pattern of both FGFR4 and ECRG1 gene with OSCC in Asian patients. In this study, FGFR4 Arg allele carrier was associated with higher N stage compared with Gly allele. If the important biological role of FGFR4 and ECRG1 in OSCC can be confirmed in further studies, this might be a rational to consider the evaluation of these genes as a therapeutic target in OSCC.
本研究旨在检测口腔鳞状细胞癌(OSCC)中 ECRG1 和 FGFR4 基因的 SNP 模式,并评估 SNP 与预后参数之间的相关性。
本研究共纳入 24 例 OSCC 患者。我们采用 PCR 和直接测序法分析 ECRG1 和 FGFR4 基因的 SNP 模式。同时,我们评估了 SNP 模式与 OSCC 临床病理参数之间的相关性。
ECRG1 基因的等位基因 Arg/Arg 型在 13 例(54.2%)患者中,Arg/Gln 型在 11 例(45.8%)患者中,Gln/Gln 型在无患者中。ECRG1 基因 SNP 模式与临床或病理因素无关。24 例 OSCC 患者 FGFR4 氨基酸 388 的等位基因类型为 Arg/Arg(8.3%)、Arg/Gly(54.2%)和 Gly/Gly(37.5%)。除了淋巴结分期外,没有临床或病理因素与 SNP 模式显著相关。与 Gly/Gly 等位基因携带组相比,携带 FGFR4 氨基酸 388 处 Arg/Arg 或 Arg/Gly 等位基因的患者与较晚的 N 分期(病理 N2+N3)相关(p=0.009)。
本研究首次描述了亚洲患者 OSCC 中 FGFR4 和 ECRG1 基因的 SNP 模式。在本研究中,与 Gly 等位基因相比,FGFR4 Arg 等位基因携带者与较高的 N 分期相关。如果 FGFR4 和 ECRG1 在 OSCC 中的重要生物学作用能在进一步的研究中得到证实,这可能为将这些基因评估为 OSCC 的治疗靶点提供合理依据。